Sponsored By

Ashland manufactures Viatel bio-resorbable polymers for long-acting release formulations, medical devices, and tissue engineering scaffolds.

August 31, 2022

1 Min Read
Ashland logo
Image courtesy of Ashland

Ireland-based Ashland has announced an expansion of its Viatel bio-resorbable polymer manufacturing and research and development site. The company is doubling its manufacturing and laboratory footprint at the National Science Park in Mullingar.

“Doubling both our footprint and the headcount of this facility allows us to deliver cutting-edge polymer chemistry by increasing scope, capacity, and capabilities, and to respond to growing customer needs with greater speed,” said Seán McMahon, PhD, Business Manager.

Viatel bio-resorbable polymers are the building blocks in long-acting release formulations, medical devices, and tissue engineering scaffolds.

“Expansion of the facility in Ireland showcases our commitment to innovation in the long-acting injectables space,” said Ashok Kalyana, Senior Vice President and General Manager, Life Sciences. “We are actively helping our customers solve for performance attributes that will ultimately allow patients to take less medicine, fewer times.”

Ashland produces more than 70 grades of lactide/glycolide/caprolactone co-polymers within its Viatel portfolio. Custom polymer production is available to serve changing customer requirements.

The capital expansion program began in June 2022; completion is expected in 2024.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like